Agenyx (ARGX) spiked off morning lows as 500 December $540 calls bought to open $14.40 to $18 aggressively into weakness. ARGX is testing and holding that large gap from July,. Vyvgart has been a strong launch story and estimates are rising and ITP/PV results in Q4 the next catalyst